Most Read Articles
2 days ago
There appears to be a high rate of emergency department (ED) admission for acute exacerbation of chronic obstructive pulmonary disease (AECOPD), with patients having significant in-hospital mortality, according to data from the *AANZDEM study. Furthermore, compliance with evidence-based treatments in the ED is suboptimal.
Tristan Manalac, 6 days ago
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
Pearl Toh, 3 days ago
Patients with inflammatory bowel disease (IBD) who had primary nonresponse to an anti-tumour necrosis factor (TNF) agent ─ or inadequate response to the initial loading doses ─ were less likely to respond to second-line biologics compared with those who had secondary loss of response (LOR) or intolerance to the primary therapy, according to a systematic review and meta-analysis presented at the Crohn's & Colitis Congress (CCC) 2018 held recently in Las Vegas, Nevada, US.
Tristan Manalac, 16 Feb 2018
Placebo pills, even when administered open-label, appear to significantly improve cancer-related fatigue and fatigue-disrupted quality of life, according to a recent study.

Psoriasis, psoriatic arthritis predispose patients to liver disease

26 Nov 2017

Patients with psoriasis (PsO) or psoriatic arthritis (PsA) appear to be at greater risk of developing serious liver disease compared with those who have rheumatoid arthritis (RA), as shown in a study.

The study followed for an average of 6 years patients with PsO (n=197,130), PsA (n=12,308) or RA (n=54,251) and matched unexposed controls (n=1,279,754) for the development of any liver disease (nonalcoholic fatty liver disease [NAFLD], cirrhosis and viral hepatitis, among others)—the primary outcome.

In the cohort, RA patients were more likely to be older, female and have more medical comorbidities. On the other hand, PsO and PsA patients receiving systemic therapy (ST) had higher body mass index (BMI). ST was prescribed in 6 percent in the PsO group, 53 percent in the PsA group and 61 percent in the RA group. Methotrexate was the most frequently used drug.

Multivariable Cox proportional hazard models showed that the risk of incident liver disease was elevated in all disease groups than in controls, with the exception of RA group prescribed an ST (adjusted hazard ratio [aHR], 0.96; 95 percent CI, 0.83 to 1.12).

The highest risk of incident liver disease was observed in the PsO group with ST (aHR, 1.97; 1.63 to 2.38), followed by the PsA group with ST (aHR, 1.67; 1.29 to 2.15), RA group without ST (aHR, 1.49; 1.26 to 1.76), PsA group without ST (aHR, 1.38; 1.02 to 1.86) and PsO group without ST (aHR, 1.37; 1.29 to 1.45).

Specifically, NAFLD (37.85 percent) was the most frequently diagnosed liver disease subtype, followed by alcoholic liver disease (18.53 percent), unknown causes (10.35 percent), viral aetiologies (7.76 percent), biliary disease (4.33 percent) and autoimmune liver disease (0.60 percent).

The present data lend empirical support to the long-held expert opinion that patients with PsO may be more predisposed to liver disease than patients with RA, researchers noted.

Physicians should inform patients regarding the increased risk of liver disease and recommend weight loss and moderation of alcohol use, and consider minimizing use of nonsteroidal anti-inflammatory drugs in combination with other hepatotoxic medications, they continued.

More studies are warranted to elucidate the role of inflammation in liver disease and, conversely, the role the liver plays in perpetuating inflammation in PsO, PsA and RA, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
2 days ago
There appears to be a high rate of emergency department (ED) admission for acute exacerbation of chronic obstructive pulmonary disease (AECOPD), with patients having significant in-hospital mortality, according to data from the *AANZDEM study. Furthermore, compliance with evidence-based treatments in the ED is suboptimal.
Tristan Manalac, 6 days ago
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
Pearl Toh, 3 days ago
Patients with inflammatory bowel disease (IBD) who had primary nonresponse to an anti-tumour necrosis factor (TNF) agent ─ or inadequate response to the initial loading doses ─ were less likely to respond to second-line biologics compared with those who had secondary loss of response (LOR) or intolerance to the primary therapy, according to a systematic review and meta-analysis presented at the Crohn's & Colitis Congress (CCC) 2018 held recently in Las Vegas, Nevada, US.
Tristan Manalac, 16 Feb 2018
Placebo pills, even when administered open-label, appear to significantly improve cancer-related fatigue and fatigue-disrupted quality of life, according to a recent study.